Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2026-03-26 @ 3:20 PM
Ignite Modification Date: 2026-03-26 @ 3:20 PM
NCT ID: NCT07335718
Eligibility Criteria: Inclusion Criteria: * Having low back pain lasting longer than 12 weeks Having a diagnosis of lumbar disc herniation (bulging, protruded, or extruded) Being able to comply with the exercise program Willingness to participate in the study Being between 20 and 60 years of age Exclusion Criteria: Being younger than 20 years or older than 60 years Having a known and/or newly diagnosed malignancy Presence of cardiac implants such as a pacemaker Having inflammatory low back pain Having absolute spinal stenosis (anteroposterior diameter of the spinal canal \< 10 mm and anteroposterior diameter of the lateral recess \< 3 mm) History of surgery due to lumbar disc herniation, lumbar spinal stenosis, vertebral fracture, or similar conditions Presence of lumbar spondylolisthesis Patients with sequestered disc herniation Patients with polyneuropathy Patients with central pain following stroke Patients with neurological deficits Having a diagnosed neurodegenerative disease Having a systemic musculoskeletal disease Patients with acute deep vein thrombosis Pregnancy Presence of infection at the skin surface where treatment will be applied Unexplained weight loss Bladder and/or bowel incontinence Having received physical therapy modalities or injections for low back pain within the last 1 month Having cognitive impairment Refusal to participate in the study \-
Healthy Volunteers: False
Sex: ALL
Minimum Age: 20 Years
Maximum Age: 60 Years
Study: NCT07335718
Study Brief:
Protocol Section: NCT07335718